Cargando…

Association of gene variants in the transforming growth factor beta signalling pathways with invasive breast cancer risk

Detalles Bibliográficos
Autores principales:	Scollen, S, Dunning, AM, Hesketh, R, Metcalfe, JC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300275/ http://dx.doi.org/10.1186/bcr1583

Ejemplares similares

Association of gene variants in the TGF-beta signalling pathways with invasive breast cancer risk
por: Scollen, S, et al.
Publicado: (2008)

From association to cause: fine mapping of the TNRC9 gene region, a novel susceptibility locus identified in the first genome-wide association study for breast cancer
por: Ahmed, S, et al.
Publicado: (2008)

Is transforming growth factor beta signalling required for breast cancer metastatic cell motility?
por: Giampieri, S, et al.
Publicado: (2006)

Epigenetic silencing of tropomyosin alters transforming growth factor beta control of cell invasion and metastasis
por: Bakin, A, et al.
Publicado: (2005)

Transforming growth factor-beta co-receptor endoglin suppresses breast cancer invasion and metastasis
por: Henry, LA, et al.
Publicado: (2010)

Development of small-molecule transforming growth factor beta antagonists
por: Warner, DJ, et al.
Publicado: (2006)

Progress towards unlocking the secrets of oestrogen receptor beta in breast cancer
por: Speirs, V, et al.
Publicado: (2006)

Transforming growth factor beta 1 gene transcription in infection and severe sepsis displays distinguishing characteristics
por: White, M, et al.
Publicado: (2008)

Are extended and continuous infusions of time dependent antibiotics used in the management of sepsis in england today?
por: Dunning, JA, et al.
Publicado: (2015)

Laminin type 1 augments the transforming growth factor beta-induced expression of matrix metalloproteinase 3 in synovial fibroblasts
por: Hoberg, M, et al.
Publicado: (2005)

Colorectal cancer patients show decrease in cellular immunity and enhanced plasma level of transforming growth factor – beta and vascular endothelial growth factor (VEGF)
por: Zavadova, Eva, et al.
Publicado: (2013)

440 Novel mechanism of transforming growth factor beta-1 signaling in human bronchial epithelia
por: Donovan, J., et al.
Publicado: (2022)

Cell differentiation and dominant signaling pathway signatures in the molecular classification of human breast cancer cell lines
por: Wilson, CA, et al.
Publicado: (2005)

Attachment of synovial fibroblasts to type 1 laminin boosts the transforming growth factor beta-induced expression of stromelysin-1 (MMP-3)
por: Aicher, WK
Publicado: (2004)

Stromal fibroblasts with nuclear β-catenin are present within breast tumours and increase proliferation and invasion of epithelial breast cancer cells
por: Verghese, E, et al.
Publicado: (2008)

Metabolic transformations in breast cancer subtypes
por: Mitra, Devina, et al.
Publicado: (2014)

Activation of synovial fibroblasts by laminin-1 and transforming growth factor beta induces expression of stromelysins independently of TNFα, IL-1β or NF-κB
por: Warstat, Katrin, et al.
Publicado: (2007)

Transforming growth factor beta (TGFβ) signaling is regulated at the pocket region of primary cilia
por: Christensen, S, et al.
Publicado: (2012)

An integrated informatics platform to facilitate transforming tissue into knowledge
por: Quinlan, PR, et al.
Publicado: (2010)

Tryptase as a PAR-2 activator in joint inflammation
por: Kelso, EB, et al.
Publicado: (2005)

Insulin-like growth factor signalling in oestrogen nonresponsive breast cancer cells
por: de Blaquiere, GE, et al.
Publicado: (2006)

Investigating the effects of beta-amyloid on hippocampal signalling in Alzheimer's disease
por: Warburton, Julia M, et al.
Publicado: (2015)

A modeling study on the signal transformation for the microsaccade generation
por: Inagaki, Keiichiro, et al.
Publicado: (2010)

Elucidating the molecular genetic basis of cluster headache: delineation of the genetic architecture by exome sequencing
por: Southgate, L, et al.
Publicado: (2013)

Detection of rare single nucleotide variants affecting genes in the DNA repair pathways in hereditary breast cancer
por: Hussein, Shireen, et al.
Publicado: (2014)

A novel and selective PDK1 inhibitor reduces breast cancer cell invasion and tumour growth
por: Raimondi, C, et al.
Publicado: (2010)

Prognostic significance of fibroblast growth factor 19 (FGF19) expression in breast invasive ductal carcinoma
por: Hakamy, Sahar, et al.
Publicado: (2014)

Regulation of estrogen receptor beta by 5' untranslated regions in breast carcinogenesis
por: Smith, L, et al.
Publicado: (2008)

Immune surveillance is thwarted by tumor-cell intrinsic beta-catenin signaling
por: Spranger, Stefani, et al.
Publicado: (2015)

Transforming epitope-specific gp120 monomer-based probes into immunogens with N-linked glycan masking
por: Chuang, G, et al.
Publicado: (2012)

Role of the Hsp90 cochaperone, FKBPL, in oestrogen receptor signalling and breast cancer growth and survival
por: McKeen, H, et al.
Publicado: (2008)

Amelioration of joint inflammation by a PAR-2-specific monoclonal antibody
por: King, V, et al.
Publicado: (2005)

Transforming Growth Factor-Beta (TGFβ) Signaling Pathway in Cholangiocarcinoma
por: Papoutsoglou, Panagiotis, et al.
Publicado: (2019)

Identification of proteins and signalling pathways involved in neoadjuvant chemotherapy responsiveness of breast tumours using proteomics
por: Greenwood, CR, et al.
Publicado: (2010)

The Transcription Factors Snail and Slug Activate the Transforming Growth Factor-Beta Signaling Pathway in Breast Cancer
por: Dhasarathy, Archana, et al.
Publicado: (2011)

The value of arbitration in a breast screening programme
por: Gilchrist, AM
Publicado: (2004)

Use of mouse models to validate and therapeutically target transforming growth factor beta as an important player in breast cancer progression
por: Wakefield, LM, et al.
Publicado: (2003)

Synergy between the erbB and transforming growth factor beta signaling networks: implications for molecular therapeutics in human neoplasia
por: Arteaga, CL
Publicado: (2003)

Establishment and characterization of two breast cancer xenografts in immunodeficient mice for studies on hormone-dependent and hormone-independent tumor growth, progression and invasion
por: Engebraaten, O, et al.
Publicado: (2005)

Primary ductal carcinoma in situ mammosphere formation: importance of the epidermal growth factor and Notch receptor signalling pathways
por: Farnie, G, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_1i83lg2shj5bo9f1qfdvfvch8a